---
document_datetime: 2025-11-23 08:01:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/mycograb.html
document_name: mycograb.html
version: success
processing_time: 0.0549963
conversion_datetime: 2025-12-28 09:59:57.724817
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Mycograb

[RSS](/en/individual-human-medicine.xml/66404)

##### Refused

This medicine has been refused authorisation

efungumab

Medicine

Human

Refused

Page contents

## Page contents

- [Overview](#overview)
- [Product details](#product-details)
- [Application details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 16 November 2006, the Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion, recommending the refusal of the marketing authorisation for the medicinal product Mycograb 2 mg/ml powder for solution for injection intended for the treatment of invasive candidiasis in adult patients, in combination with amphotericin B or a lipid formulation of amphotericin B.

The company that applied for authorisation is NeuTec Pharma plc. The applicant requested a reexamination of the opinion.

After having considered the grounds for this request, the CHMP reexamined the initial opinion, and confirmed the refusal of the marketing authorisation on 20 March 2007.

Questions and answers on the recommendation for the refusal of the marketing authorization for Mycograb

English (EN) (34.38 KB - PDF)

**First published:** 21/03/2007

**Last updated:** 21/03/2007

[View](/en/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_en.pdf)

[Other languages (21)](#file-language-dropdown-749)

български (BG) (140.06 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/bg/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_bg.pdf)

español (ES) (34.92 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/es/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_es.pdf)

čeština (CS) (122.04 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/cs/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_cs.pdf)

dansk (DA) (34.56 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/da/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_da.pdf)

Deutsch (DE) (35.59 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/de/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_de.pdf)

eesti keel (ET) (34.34 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/et/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_et.pdf)

ελληνικά (EL) (131.67 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/el/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_el.pdf)

français (FR) (35.38 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/fr/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_fr.pdf)

italiano (IT) (35.17 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/it/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_it.pdf)

latviešu valoda (LV) (123.74 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/lv/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_lv.pdf)

lietuvių kalba (LT) (118.82 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/lt/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_lt.pdf)

magyar (HU) (115.52 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/hu/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_hu.pdf)

Malti (MT) (126.82 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/mt/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_mt.pdf)

Nederlands (NL) (35.55 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/nl/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_nl.pdf)

polski (PL) (123.88 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/pl/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_pl.pdf)

português (PT) (35.01 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/pt/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_pt.pdf)

română (RO) (118.6 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/ro/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_ro.pdf)

slovenčina (SK) (120 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/sk/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_sk.pdf)

slovenščina (SL) (113.73 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/sl/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_sl.pdf)

Suomi (FI) (34.59 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/fi/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_fi.pdf)

svenska (SV) (34.96 KB - PDF)

**First published:**

21/03/2007

**Last updated:**

21/03/2007

[View](/sv/documents/smop-initial/questions-and-answers-recommendation-refusal-marketing-authorization-mycograb_sv.pdf)

## Product details

Name of medicine Mycograb Active substance recombinant human monoclonal antibody to hsp International non-proprietary name (INN) or common name efungumab Therapeutic area (MeSH) Candidiasis Anatomical therapeutic chemical (ATC) code J02

### Pharmacotherapeutic group

Antimycotics for systemic use

## Application details

EMA product number EMEA/H/C/000658 Marketing authorisation applicant NeuTec Pharma plc Opinion adopted 20/03/2007 Refusal of marketing authorisation 22/05/2007

## Assessment history

Mycograb : EPAR - Refusal public assessment report

English (EN) (370.81 KB - PDF)

**First published:** 22/10/2007

**Last updated:** 22/10/2007

[View](/en/documents/assessment-report/mycograb-epar-refusal-public-assessment-report_en.pdf)

**This page was last updated on** 21/03/2007

## Share this page

[Back to top](#main-content)